Blend Labs (BLND) Competitors $4.22 -0.03 (-0.71%) Closing price 09/18/2025 03:59 PM EasternExtended Trading$4.22 0.00 (0.00%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BLND vs. CLBT, KC, VERX, TENB, FRSH, INTA, MGNI, NCNO, ZI, and AVPTShould you be buying Blend Labs stock or one of its competitors? The main competitors of Blend Labs include Cellebrite DI (CLBT), Kingsoft Cloud (KC), Vertex (VERX), Tenable (TENB), Freshworks (FRSH), Intapp (INTA), Magnite (MGNI), nCino (NCNO), ZoomInfo Technologies (ZI), and AvePoint (AVPT). These companies are all part of the "computer software" industry. Blend Labs vs. Its Competitors Cellebrite DI Kingsoft Cloud Vertex Tenable Freshworks Intapp Magnite nCino ZoomInfo Technologies AvePoint Cellebrite DI (NASDAQ:CLBT) and Blend Labs (NYSE:BLND) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation. Is CLBT or BLND more profitable? Blend Labs has a net margin of -14.26% compared to Cellebrite DI's net margin of -34.56%. Cellebrite DI's return on equity of 23.92% beat Blend Labs' return on equity.Company Net Margins Return on Equity Return on Assets Cellebrite DI-34.56% 23.92% 11.94% Blend Labs -14.26%N/A -4.24% Do analysts recommend CLBT or BLND? Cellebrite DI currently has a consensus price target of $22.40, indicating a potential upside of 25.35%. Blend Labs has a consensus price target of $4.88, indicating a potential upside of 15.72%. Given Cellebrite DI's stronger consensus rating and higher probable upside, equities analysts clearly believe Cellebrite DI is more favorable than Blend Labs.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cellebrite DI 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Blend Labs 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.86 Which has preferable earnings & valuation, CLBT or BLND? Blend Labs has lower revenue, but higher earnings than Cellebrite DI. Blend Labs is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCellebrite DI$401.20M10.67-$283.01M-$0.76-23.51Blend Labs$162.02M6.76-$43.35M-$0.15-28.13 Does the media refer more to CLBT or BLND? In the previous week, Cellebrite DI had 3 more articles in the media than Blend Labs. MarketBeat recorded 6 mentions for Cellebrite DI and 3 mentions for Blend Labs. Cellebrite DI's average media sentiment score of 1.22 beat Blend Labs' score of 1.15 indicating that Cellebrite DI is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cellebrite DI 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Blend Labs 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in CLBT or BLND? 45.9% of Cellebrite DI shares are owned by institutional investors. Comparatively, 52.6% of Blend Labs shares are owned by institutional investors. 5.7% of Cellebrite DI shares are owned by insiders. Comparatively, 35.5% of Blend Labs shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more risk & volatility, CLBT or BLND? Cellebrite DI has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500. Comparatively, Blend Labs has a beta of 1.25, suggesting that its stock price is 25% more volatile than the S&P 500. SummaryCellebrite DI beats Blend Labs on 11 of the 17 factors compared between the two stocks. Get Blend Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for BLND and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLND and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLND vs. The Competition Export to ExcelMetricBlend LabsINTERNET SOFTWARE IndustryComputer SectorNYSE ExchangeMarket Cap$1.10B$20.18B$31.80B$21.54BDividend YieldN/A3.53%3.17%3.50%P/E Ratio-28.1380.77452.5930.17Price / Sales6.7694.141,917.5975.23Price / CashN/A84.3737.2024.62Price / Book-19.189.137.524.58Net Income-$43.35M$355.93M$809.77M$1.00B7 Day Performance-2.09%3.33%4.04%1.52%1 Month Performance39.97%10.67%9.21%5.96%1 Year Performance6.03%79.51%24,200.42%14.24% Blend Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLNDBlend Labs2.5763 of 5 stars$4.22-0.7%$4.88+15.7%+8.1%$1.10B$162.02M-28.131,690Positive NewsCLBTCellebrite DI3.0384 of 5 stars$17.09+2.9%$22.40+31.1%+3.6%$3.98B$401.20M-22.491,167Positive NewsKCKingsoft Cloud1.7422 of 5 stars$14.12+2.2%$15.40+9.1%+656.9%$3.86B$1.07B-12.3912,355Positive NewsAnalyst ForecastVERXVertex3.9593 of 5 stars$25.93+7.9%$43.69+68.5%-29.5%$3.83B$666.78M-78.571,900Positive NewsTENBTenable4.9287 of 5 stars$31.16+0.4%$41.06+31.8%-23.3%$3.76B$900.02M-84.211,872Positive NewsFRSHFreshworks3.4506 of 5 stars$13.14+2.3%$20.29+54.4%+18.0%$3.74B$720.42M-73.004,400INTAIntapp3.5886 of 5 stars$45.34+1.4%$60.63+33.7%-5.6%$3.67B$504.12M-188.921,336Positive NewsMGNIMagnite3.628 of 5 stars$25.35+2.0%$25.82+1.8%+79.5%$3.54B$668.17M87.42950Analyst ForecastInsider TradeNCNOnCino3.2316 of 5 stars$30.83+1.4%$33.94+10.1%+2.2%$3.52B$540.66M-106.311,833ZIZoomInfo Technologies0.654 of 5 stars$10.23+1.1%$11.18+9.3%+16.0%$3.50B$1.21B341.113,540Positive NewsAVPTAvePoint3.0862 of 5 stars$16.57+1.8%$20.80+25.5%+36.9%$3.45B$330.48M-331.332,934Positive NewsAnalyst Revision Related Companies and Tools Related Companies Cellebrite DI Competitors Kingsoft Cloud Competitors Vertex Competitors Tenable Competitors Freshworks Competitors Intapp Competitors Magnite Competitors nCino Competitors ZoomInfo Technologies Competitors AvePoint Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BLND) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Blend Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Blend Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
